Navigation Links
Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
Date:11/1/2012

PARSIPPANY, N.J., Nov. 1, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today reported net income for the third quarter 2012 increased 24.2 percent to $172.3 million or $1.35 per diluted share on a non-GAAP basis, compared to $138.7 million or $1.09 per diluted share in the third quarter 2011.  Non-GAAP net income for the third quarter 2012 included $6.7 million or $0.05 per share related to the favorable settlement of a tax audit and other tax benefits realized in the quarter. Net revenue increased 18.8 percent to $1.29 billion, compared to $1.08 billion in the third quarter 2011. On a GAAP basis, net income increased by $8.6 million or 13 percent to $76.7 million or $0.60 per diluted share compared to earnings of $68.1 million or $0.54 per diluted share in the third quarter 2011. 

For the third quarter 2012, adjusted EBITDA increased 18 percent to $304.6 million, compared to $258.2 million in the third quarter 2011.  Refer to the attached reconciliation tables for adjustments to GAAP earnings.  Cash flow from operations was $145.9 million and cash and marketable securities were $234.4 million at September 30, 2012.

"Our third quarter 2012 double digit growth in global revenues, non-GAAP earnings and adjusted EBITDA represents another quarter of solid growth and strong execution at Watson," said Paul Bisaro, President and CEO. "We are very pleased that as we transition from Watson stand-alone to a larger company following the Actavis acquisition, we have demonstrated outstanding execution of our 2012 business plan. We delivered this performance while we simultaneously focused on integration planning and are now ready to capitalize on our objectives for uniting Watson and Actavis, and creating a larger, more powerful global competitor."

"During the quarter, Watson received a number of important FDA approvals including generic
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
2. Watson to Acquire Actavis Group for EUR4.25 Billion
3. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
4. Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
5. Watson Confirms Lo Loestrin® Fe Patent Challenge
6. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
7. Watson Confirms Testim® Patent Challenge
8. Watson to Present at the Jefferies 2012 Global Healthcare Conference
9. Watson Announces Lidoderm® Patent Challenge Settlement
10. Endo Announces Resolution of Patent Litigation with Watson Pharmaceuticals Related to Lidoderm®
11. Watson to Host Second Quarter 2012 Earnings Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... overview and update at the NewsMakers in the Biotech ... a.m. Eastern Time (8:30 a.m. Pacific Time), at the ... . A live audio webcast of ... section of Arena,s website at www.arenapharm.com . A ...
(Date:9/22/2014)... 2014 According to the ... Product (Equipment, Media and Reagents), by Source, by ... medicine, Toxicity Testing, Research, Drug Discovery) - Analysis ... analyzes and studies the major market drivers, threats, ... market data tables and 64 figures spread through ...
(Date:9/22/2014)... , Sept. 22, 2014 CytRx Corporation ... development company specializing in oncology, today announced that study ... clinical trials of aldoxorubicin, a pivotal global Phase 3 ... a global Phase 2b clinical trial in small cell ... for Medical Oncology (ESMO) 2014 Congress being held September ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6
... 10, 2012  Wells Pharmacy Network President, Robert L. ... opening of Wells Pharmacy,s corporate headquarters. Located in ... pharmacy is focused on serving the unique needs ... Compounding combines the art and skill of pharmacy with the ...
... PULLMAN, Wash., Jan. 10, 2012 The AquaLab ... Devices allows scientists to better understand moisture in products ... is influenced by temperature and humidity changes can reveal ... shelf-life.  This type of measurement is called an isotherm.  ...
Cached Medicine Technology:"Wells Pharmacy Network" a Premier Compounding Pharmacy Focused on Serving the Unique Needs of the Medical and Veterinarian Communities Opens in Wellington 2New AquaLab Vapor Sorption Analyzer Puts Isotherm Technology Within Financial Reach of Food and Pharmaceutical Scientists 2
(Date:9/22/2014)... Downers Grove, IL (PRWEB) September 22, 2014 ... a complimentary webinar titled "From Divorce Talk to Solution ... of Couples Sessions.” The 60-minute webinar, presented by special ... September 24th, at 1pm Central Standard Time. , ... Divorce Talk to Solution Talk: Solution Focused Brief Therapy ...
(Date:9/22/2014)... 2014 In CHAMPS Patient Experience's most ... Leader’s Board Summer Meeting , Toya Gorley shares her ... of attending The Leader’s Board meeting this summer, which ... found this experience to be exhilarating! Many topics were ... price transparency on the patient experience , ...
(Date:9/22/2014)... Mississauga, Ontario (PRWEB) September 22, 2014 ... August 1st, 2014 at the PWN International Conference in ... Canadian release that was celebrated with a reception attended ... this reception Dawn shared insights she had gained while ... organizational side of the glass ceiling issue, and what ...
(Date:9/22/2014)... 2014 Fancyflyingfox.com, the well-known wedding dress manufacturer ... plus size wedding dresses . In addition, the company ... fashionable plus size outfits. Each item in the new range ... 65% off. , The company has thousands of unique ... now available at extremely affordable prices. Its products are brand ...
(Date:9/21/2014)... CA (PRWEB) September 22, 2014 CareSpan ... it has entered into a joint services agreement with ... Dakota, to deploy the CareSpan Virtual Clinic in multiple ... Avera eCARE plan to deploy their joint services in ... and Wyoming where Avera eCARE is licensed. The two ...
Breaking Medicine News(10 mins):Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 2Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 3Health News:CHAMPS' Toya Gorley Discusses the Thought-Provoking Conversation at The Leader’s Board Summer Meeting 2Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Discounted Plus Size Wedding Dresses Available At Fancyflyingfox.com 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3
... Benefit for Health-Conscious ... ... ), a leading supplier of health screening and data,management services, announced ... software, is offering BioIQ,s home test,kits to its entire U.S. workforce. ...
... for an aging parent are playing an active role when it comes ... ... November 11, 2008 -- According to a new survey from Caring.com, baby ... it comes to decisions about their parents, medications. , , ,The new ...
... being recognized as one of the top performing California physician groups ... Partners is one of only four California Physicians groups in the ... ... (PRWEB) November 11, 2008 -- This is the fifth straight ...
... The 2008 Frost &,Sullivan Global Appetite Suppressant ... is presented to Gencor Pacific Group for,successfully creating ... the global weight management market. The compelling,scientific validation, ... of Slimaluma have established it at the forefront ...
... hypertension contributes to the deaths of almost 8,000 black ... to a first-of-its-kind study published today in the ... Medical Center researchers. , The researchers concluded that the ... their hypertension, or high blood pressure, controlled to the ...
... State agriculture,and health officials touring the state to gain ... made four stops in,northeastern Pennsylvania today., Agriculture Secretary ... area as part of the Strategy for Agriculture and ... to address,food safety and defense from the farm to ...
Cached Medicine News:Health News:Software Vendor QAD Rolls Out BioIQ Health Testing Program to National Workforce 2Health News:Boomers Play an Active Role with Parent's Medication Decisions 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 3Health News:Gencor Pacific Group Picks Up Frost & Sullivan Global Appetite Suppressant and Satiety Ingredients Product Innovation of the Year Award 2Health News:Gencor Pacific Group Picks Up Frost & Sullivan Global Appetite Suppressant and Satiety Ingredients Product Innovation of the Year Award 3Health News:Blood pressure control inequality linked to deaths among blacks 2Health News:Agriculture, Health Officials Address Food Safety Concerns During Northeastern PA Tour 2
Force 1C has a streamlined, compact design perfect for the requirements of outpatient surgery - as well as the power and performance features needed for a full range of general inpatient surgical pro...
3.2 mm Keratome, double bevel, sharp sides, ang. 1 Ea as quantity....
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
Lombart clip-on occluder...
Medicine Products: